sechenovSechenov Medical JournalСеченовский вестник2218-73322658-3348Сеченовский Университетsechenov-658Research ArticleUROLOGY AND NEPHROLOGYУРОЛОГИЯ И НЕФРОЛОГИЯDIURETIC RESISTANCE AS A GENERAL CLINICAL PROBLEMРЕЗИСТЕНТНОСТЬ К ДИУРЕТИКАМ КАК ОБЩЕКЛИНИЧЕСКАЯ ПРОБЛЕМАМухинН. А.MukhinN. A.

дм.н., профессор, академик РАМН, заведующий кафедрой терапии и профболезней медико-профилактического факультета, директор клиники нефрологии, внутренних и профессиональных болезней им. Е.М. Тареева Университетской клинической больницы № 3

ФоминВ. В.FominV. V.

дм.н., профессор кафедры терапии и профболезней медико-профилактического факультета, декан факультета довузовского образования

ПулинА. А.PulinA. A.

км.н., ассистент кафедры терапии и профболезней медико-профилактического факультета

ГОУ ВПО «Первый Московский государственный медицинский университет им. И.М. Сеченова Минздравсоцразвития России»Russian Federation201030062010025155Copyright © Mukhin N.A., Fomin V.V., Pulin A.A., 20102010Мухин Н.А., Фомин В.В., Пулин А.А.Mukhin N.A., Fomin V.V., Pulin A.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.sechenovmedj.com/jour/article/view/658

Etiology, pathogenesis and treatment strategies in diuretic-resistant oedema are discussed

Представлены причины, механизмы развития и подходы к устранению резистентности к диуретикам

резистентность к диуретикамотекилечениеdiuretic resistanceedematreatmentReferencesAl-Sheikh А.А.К., van der Heuvel Koenderink J.B., Russel FG.M. Effect of hypouricaemic and hyperuricaemic drugs on the renal urate efflux transporter, multidrug resistance protein 4 / / Br. J. Pahrmacol. — 2008. — Vol. 155. - P. 1066-1075.Al-Sheikh А.А.К., van der Heuvel Koenderink J.B., Russel FG.M. Effect of hypouricaemic and hyperuricaemic drugs on the renal urate efflux transporter, multidrug resistance protein 4 / / Br. J. Pahrmacol. — 2008. — Vol. 155. - P. 1066-1075.Bleich M., Greger R. Mechanism of action of diuretics / / Kidney Int. - 1997. - Vol. 51, suppl. 59. - P. S11-S15.Bleich M., Greger R. Mechanism of action of diuretics / / Kidney Int. - 1997. - Vol. 51, suppl. 59. - P. S11-S15.Boesken W.H., Kult J. High-dose torasemide, given once daily intravenously for one week, in patients with advanced chronic renal failure / / Clin. Nephrol. — 1997. — Vol. 48, N 1. - P. 22-28.Boesken W.H., Kult J. High-dose torasemide, given once daily intravenously for one week, in patients with advanced chronic renal failure / / Clin. Nephrol. — 1997. — Vol. 48, N 1. - P. 22-28.Bramham K., Hunt B.J., Goldsmith D. Thrombophilia of nephrotic syndrome in adults / / Clin. Adv. Hematol. Oncol. - 2009. - Vol. 7, N 6. - P. 368-372.Bramham K., Hunt B.J., Goldsmith D. Thrombophilia of nephrotic syndrome in adults / / Clin. Adv. Hematol. Oncol. - 2009. - Vol. 7, N 6. - P. 368-372.Chui M.A., Deer M., Bennett S.J. et al. Association between adherence to diuretic therapy and health care utilization in patients with heart failure // Pharmacotherapy. — 2003. — Vol. 23, N 3. - P. 326-332.Chui M.A., Deer M., Bennett S.J. et al. Association between adherence to diuretic therapy and health care utilization in patients with heart failure // Pharmacotherapy. — 2003. — Vol. 23, N 3. - P. 326-332.Dougall H. T, Me Lay J. A comparative review of the adverse effects of calcium antagonists / / Drug Saf. — 1996. — Vol. 15, N 2 , - P.91-106.Dougall H. T, Me Lay J. A comparative review of the adverse effects of calcium antagonists / / Drug Saf. — 1996. — Vol. 15, N 2 , - P.91-106.Dunn C.J., FittonA., Brogden R.N. Torasemide. An updateof its pharmacological properties and therapeutic efficacy // Drugs. - 1995. - Vol. 49, N 1. - P. 121-142.Dunn C.J., FittonA., Brogden R.N. Torasemide. An updateof its pharmacological properties and therapeutic efficacy // Drugs. - 1995. - Vol. 49, N 1. - P. 121-142.Fliser D., Schroter M., Neubeck M. et al. Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failure / / Kidney Int. — 1994. — Vol. 46, N 2. - P. 482-488.Fliser D., Schroter M., Neubeck M. et al. Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failure / / Kidney Int. — 1994. — Vol. 46, N 2. - P. 482-488.Gehr T.W., Rudy D.W., Matzke G.R. et al. The pharmacokinetics of intravenous and oral torsemide in patients with chronic renal insufficiency / / Clin. Pharmacol. Ther. — 1994. - Vol. 56, N 1. - P. 31-38.Gehr T.W., Rudy D.W., Matzke G.R. et al. The pharmacokinetics of intravenous and oral torsemide in patients with chronic renal insufficiency / / Clin. Pharmacol. Ther. — 1994. - Vol. 56, N 1. - P. 31-38.Greenberg A. Diuretic complications //Am. J. Med. Sci. —* 2000. - Vol. 319, N 1. - P. 10-24.Greenberg A. Diuretic complications //Am. J. Med. Sci. —* 2000. - Vol. 319, N 1. - P. 10-24.Hunter D.J., York M., Chaisson C.E. et al. Recent diuretic use and the risk of recurrent gout attacks: the online casecrossover gout study / / J. Rheumatol. — 2006. — Vol. 33, N 7. - P. 1341-1345.Hunter D.J., York M., Chaisson C.E. et al. Recent diuretic use and the risk of recurrent gout attacks: the online casecrossover gout study / / J. Rheumatol. — 2006. — Vol. 33, N 7. - P. 1341-1345.Kim E.J., Lee M.G. Pharmacokinetics and pharmacodynamics of intravenous trasemide in mutant Nagase analbuminemic rats // Biopharm. Drug Dispos. — 2003. — Vol. 24, N 1. - P. 27-35.Kim E.J., Lee M.G. Pharmacokinetics and pharmacodynamics of intravenous trasemide in mutant Nagase analbuminemic rats // Biopharm. Drug Dispos. — 2003. — Vol. 24, N 1. - P. 27-35.Lyseng-Williamson K.A. Torasemide prolonged release // Drugs. - 2009. - Vol. 69, N 10. - P. 1363-13.72.Lyseng-Williamson K.A. Torasemide prolonged release // Drugs. - 2009. - Vol. 69, N 10. - P. 1363-13.72.MacFadyen R.J., Gorski J.C., Brater D.C., Struthers A.D. Furosemide responsiveness, non-adherence and resistance during the chronic treatment of heart failure: a longitudinal study / / Br. J. Clin. Pharmacol. — 2004. — Vol. 57, N 5. - P. 622-631.MacFadyen R.J., Gorski J.C., Brater D.C., Struthers A.D. Furosemide responsiveness, non-adherence and resistance during the chronic treatment of heart failure: a longitudinal study / / Br. J. Clin. Pharmacol. — 2004. — Vol. 57, N 5. - P. 622-631.Muller K., Gamba G., Jaquet F., Hess B. Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA II to IV — efficacy and quality of life / / Eur. J. Heart Fail. — 2003. — Vol. 5, N 6. — P. 793-801.Muller K., Gamba G., Jaquet F., Hess B. Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA II to IV — efficacy and quality of life / / Eur. J. Heart Fail. — 2003. — Vol. 5, N 6. — P. 793-801.Orth S.R., Ritz E. The nephritic syndrome / / N. Engl. J. Med. - 1998. - Vol. 338. - P. 1202-1211.Orth S.R., Ritz E. The nephritic syndrome / / N. Engl. J. Med. - 1998. - Vol. 338. - P. 1202-1211.Patel B.V., Remigio-Baker R.A., Thiebaud P. et al. Improved persistence and adherence to diuretic fixed-dose combination therapy compared to diuretic monotherapy // BMC Fam. Pract. — 2008. — Vol. 9. — P. 61.Patel B.V., Remigio-Baker R.A., Thiebaud P. et al. Improved persistence and adherence to diuretic fixed-dose combination therapy compared to diuretic monotherapy // BMC Fam. Pract. — 2008. — Vol. 9. — P. 61.Sukl W.N. Use of diuretics in chronic renal failure // Kidney Int. — 1997. — Vol. 51, suppl. 59. — P. S33—S35.Sukl W.N. Use of diuretics in chronic renal failure // Kidney Int. — 1997. — Vol. 51, suppl. 59. — P. S33—S35.Taniguchi A., Kamatani N. Control of renal uric acid excretion and gout / / Curr. Opin. Rheumatol. — 2008. — Vol. 20, N 2. - P. 192-197.Taniguchi A., Kamatani N. Control of renal uric acid excretion and gout / / Curr. Opin. Rheumatol. — 2008. — Vol. 20, N 2. - P. 192-197.Tesar V., Zima T., Kalousova M. Pathobiochemistry of nephrotic syndrome //Adv. Clin. Chem. — 2003. — Vol. 37. — P. 173—218.Tesar V., Zima T., Kalousova M. Pathobiochemistry of nephrotic syndrome //Adv. Clin. Chem. — 2003. — Vol. 37. — P. 173—218.Valentin J.P., Qiu C., Muldowney W.P. et al. Cellular basis for blunted volume expansion natriuresis in experimental nephrotic syndrome // J. Clin. Invest. — 1992. — Vol. 90, N4. - P. 1302-1312.Valentin J.P., Qiu C., Muldowney W.P. et al. Cellular basis for blunted volume expansion natriuresis in experimental nephrotic syndrome // J. Clin. Invest. — 1992. — Vol. 90, N4. - P. 1302-1312.

The authors declare that there are no conflicts of interest present.